{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:55:09Z","timestamp":1790250909383,"version":"4.1.0"},"reference-count":74,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The recent outbreaks of Zika virus (ZIKV) infections and associated microcephaly in newborns has resulted in an unprecedented effort by researchers to target this virus. Significant advances have been made in developing vaccine candidates, treatment strategies and diagnostic assays in a relatively short period of time. Being a preventable disease, the first line of defense against ZIKV would be to vaccinate the highly susceptible target population, especially pregnant women. Along those lines, several vaccine candidates including purified inactivated virus (PIV), live attenuated virus (LAV), virus like particles (VLP), DNA, modified RNA, viral vectors and subunit vaccines have been in the pipeline with several advancing to clinical trials. As the primary objective of Zika vaccination is the prevention of vertical transmission of the virus to the unborn fetus, the safety and efficacy requirements for this vaccine remain unique when compared to other diseases. This review will discuss these recent advances in the field of Zika vaccine development.<\/jats:p>","DOI":"10.3390\/v10110631","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T10:58:22Z","timestamp":1542193102000},"page":"631","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Recent Advances in Zika Virus Vaccines"],"prefix":"10.3390","volume":"10","author":[{"given":"Himanshu","family":"Garg","sequence":"first","affiliation":[{"name":"Center of Emphasis in Infectious Diseases, Department of Biomedical Science, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-9446","authenticated-orcid":false,"given":"Tugba","family":"Mehmetoglu-Gurbuz","sequence":"additional","affiliation":[{"name":"Center of Emphasis in Infectious Diseases, Department of Biomedical Science, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Joshi","sequence":"additional","affiliation":[{"name":"Center of Emphasis in Infectious Diseases, Department of Biomedical Science, Texas Tech University Health Sciences Center, El Paso, TX 79905, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","article-title":"Zika virus: History, emergence, biology, and prospects for control","volume":"130","author":"Weaver","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3201\/eid1509.090442","article-title":"Zika virus outside Africa","volume":"15","author":"Hayes","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1056\/NEJMoa0805715","article-title":"Zika virus outbreak on Yap Island, Federated States of Micronesia","volume":"360","author":"Duffy","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0035-9203(56)90090-6","article-title":"Zika virus infection experimentally induced in a human volunteer","volume":"50","author":"Bearcroft","year":"1956","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0035-9203(64)90201-9","article-title":"Zika Virus Infection in Man","volume":"58","author":"Simpson","year":"1964","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(16)00003-9","article-title":"Zika virus genome from the Americas","volume":"387","author":"Enfissi","year":"2016","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.mi.44.100190.003245","article-title":"Flavivirus genome organization, expression, and replication","volume":"44","author":"Chambers","year":"1990","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00705-006-0903-z","article-title":"Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses","volume":"152","author":"Kuno","year":"2007","journal-title":"Arch. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv. Virus Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1073\/pnas.90.13.6218","article-title":"Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3","volume":"90","author":"Lobigs","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1128\/JVI.77.7.4370-4382.2003","article-title":"Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus","volume":"77","author":"Lorenz","year":"2003","journal-title":"J. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0042-6822(92)90317-I","article-title":"Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis","volume":"187","author":"Pincus","year":"1992","journal-title":"Virology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/viro.1995.1516","article-title":"Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection","volume":"212","author":"Pugachev","year":"1995","journal-title":"Virology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/jvi.70.7.4549-4557.1996","article-title":"Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions","volume":"70","author":"Schalich","year":"1996","journal-title":"J. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virusres.2016.10.005","article-title":"The flavivirus capsid protein: Structure, function and perspectives towards drug design","volume":"227","author":"Oliveira","year":"2017","journal-title":"Virus Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0264-410X(00)00209-7","article-title":"A truncated variant of the hepatitis C virus core induces a slow but potent immune response in mice following DNA immunization","volume":"19","author":"Herrera","year":"2000","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chen, S., Wu, Z., Wang, M., and Cheng, A. (2017). Innate Immune Evasion Mediated by Flaviviridae Non-Structural Proteins. Viruses, 9.","DOI":"10.3390\/v9100291"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e01390-17","DOI":"10.1128\/mBio.01390-17","article-title":"High Zika Virus Seroprevalence in Salvador, Northeastern Brazil Limits the Potential for Further Outbreaks","volume":"8","author":"Netto","year":"2017","journal-title":"mBio"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.stem.2016.02.016","article-title":"Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth","volume":"18","author":"Tang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.celrep.2017.10.016","article-title":"Functional Analysis of Glycosylation of Zika Virus Envelope Protein","volume":"21","author":"Shan","year":"2017","journal-title":"Cell Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.15585\/mmwr.mm6613e1","article-title":"Vital Signs: Update on Zika Virus-Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure\u2014U.S. Zika Pregnancy Registry, 2016","volume":"66","author":"Reynolds","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Krauer, F., Riesen, M., Reveiz, L., Oladapo, O.T., Martinez-Vega, R., Porgo, T.V., Haefliger, A., Broutet, N.J., Low, N., and WHO Zika Causality Working Group (2017). Zika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain-Barre Syndrome: Systematic Review. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002203"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/M17-0641","article-title":"Evaluating Vaccination Strategies for Zika Virus in the Americas","volume":"168","author":"Durham","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/14760584.2017.1345309","article-title":"An update on Zika vaccine developments","volume":"16","author":"Durbin","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kudchodkar, S.B., Choi, H., Reuschel, E.L., Esquivel, R., Jin-Ah Kwon, J., Jeong, M., Maslow, J.N., Reed, C.C., White, S., and Kim, J.J. (2018). Rapid response to an emerging infectious disease\u2014Lessons learned from development of a synthetic DNA vaccine targeting Zika virus. Microbes Infect.","DOI":"10.1016\/j.micinf.2018.03.001"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1126\/science.aai9137","article-title":"Rapid development of a DNA vaccine for Zika virus","volume":"354","author":"Dowd","year":"2016","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1038\/npjvaccines.2016.21","article-title":"In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine","volume":"1","author":"Muthumani","year":"2016","journal-title":"NPJ Vaccines"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: Randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet"},{"key":"ref_31","unstructured":"Tebas, P., Roberts, C.C., Muthumani, K., Reuschel, E.L., Kudchodkar, S.B., Zaidi, F.I., White, S., Khan, A.S., Racine, T., and Choi, H. (2017). Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine\u2014Preliminary Report. N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"eaao4163","DOI":"10.1126\/scitranslmed.aao4163","article-title":"Durability and correlates of vaccine protection against Zika virus in rhesus monkeys","volume":"9","author":"Abbink","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: Phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"46375","DOI":"10.1038\/srep46375","article-title":"Protective efficacy of Zika vaccine in AG129 mouse model","volume":"7","author":"Sumathy","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ebiom.2017.02.003","article-title":"A cDNA Clone-Launched Platform for High-Yield Production of Inactivated Zika Vaccine","volume":"17","author":"Yang","year":"2017","journal-title":"EBioMedicine"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-017-0566-9","article-title":"Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks in Modern Day","volume":"19","author":"Collins","year":"2017","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_38","first-page":"105","article-title":"Japanese encephalitis vaccines: Current vaccines and future prospects","volume":"267","author":"Monath","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nm.4322","article-title":"A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models","volume":"23","author":"Shan","year":"2017","journal-title":"Nat. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41467-017-00737-8","article-title":"A single-dose live-attenuated vaccine prevents Zika virus pregnancy transmission and testis damage","volume":"8","author":"Shan","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ebiom.2018.08.056","article-title":"A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity","volume":"36","author":"Zou","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e02134-16","DOI":"10.1128\/mBio.02134-16","article-title":"Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis","volume":"8","author":"Xie","year":"2017","journal-title":"mBio"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41467-018-02975-w","article-title":"Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone","volume":"9","author":"Li","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_44","first-page":"686549","article-title":"Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice","volume":"2013","author":"Wang","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e00834-17","DOI":"10.1128\/JVI.00834-17","article-title":"Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus","volume":"91","author":"Garg","year":"2017","journal-title":"J. Virol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Boigard, H., Alimova, A., Martin, G.R., Katz, A., Gottlieb, P., and Galarza, J.M. (2017). Zika virus-like particle (VLP) based vaccine. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005608"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7679","DOI":"10.1038\/s41598-017-08247-9","article-title":"Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2017.12.010","article-title":"Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge","volume":"27","author":"Espinosa","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.vaccine.2018.01.056","article-title":"Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells","volume":"36","author":"Basu","year":"2018","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12250-018-0030-5","article-title":"Zika Virus Baculovirus-Expressed Virus-Like Particles Induce Neutralizing Antibodies in Mice","volume":"33","author":"Dai","year":"2018","journal-title":"Virol. Sin."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Salvo, M.A., Kingstad-Bakke, B., Salas-Quinchucua, C., Camacho, E., and Osorio, J.E. (2018). Zika virus like particles elicit protective antibodies in mice. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006210"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1093\/nar\/gkr586","article-title":"Nucleoside modifications in RNA limit activation of 2\u2032-5\u2032-oligoadenylate synthetase and increase resistance to cleavage by RNase L.","volume":"39","author":"Anderson","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Kariko","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nature21428","article-title":"Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination","volume":"543","author":"Pardi","year":"2017","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mRNA Vaccines Protect against Zika Virus Infection","volume":"169","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","article-title":"Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease","volume":"170","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41598-017-00193-w","article-title":"An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model","volume":"7","author":"Chahal","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/j.vaccine.2010.01.022","article-title":"Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys","volume":"28","author":"Clements","year":"2010","journal-title":"Vaccine"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1016\/j.vaccine.2008.08.011","article-title":"Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser)","volume":"26","author":"Jarvi","year":"2008","journal-title":"Vaccine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e00576-17","DOI":"10.1128\/mSphere.00576-17","article-title":"Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice","volume":"3","author":"To","year":"2018","journal-title":"mSphere"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41426-017-0007-8","article-title":"Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses","volume":"7","author":"Tai","year":"2018","journal-title":"Emerg. Microbes Infect."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1016\/j.vaccine.2017.04.052","article-title":"Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus","volume":"35","author":"Yang","year":"2017","journal-title":"Vaccine"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/pbi.12796","article-title":"Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice","volume":"16","author":"Yang","year":"2018","journal-title":"Plant Biotechnol. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2018.04.010","article-title":"Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection","volume":"154","author":"Qu","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40478-018-0572-7","article-title":"E90 subunit vaccine protects mice from Zika virus infection and microcephaly","volume":"6","author":"Zhu","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e01722-17","DOI":"10.1128\/JVI.01722-17","article-title":"Recombinant Chimpanzee Adenovirus Vaccine AdC7-M\/E Protects against Zika Virus Infection and Testis Damage","volume":"92","author":"Xu","year":"2018","journal-title":"J. Virol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Cox, F., van der Fits, L., Abbink, P., Larocca, R.A., van Huizen, E., Saeland, E., Verhagen, J., Peterson, R., Tolboom, J., and Kaufmann, B. (2018). Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202820"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1038\/s41467-018-04859-5","article-title":"Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors","volume":"9","author":"Abbink","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-018-0072-6","article-title":"Incorporation of NS1 and prM\/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein","volume":"3","author":"Liu","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/s41467-018-03662-6","article-title":"A vaccinia-based single vector construct multi-pathogen vaccine protects against both Zika and chikungunya viruses","volume":"9","author":"Prow","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.4049\/jimmunol.1602180","article-title":"Cutting Edge: Innate Immune Augmenting Vesicular Stomatitis Virus Expressing Zika Virus Proteins Confers Protective Immunity","volume":"198","author":"Betancourt","year":"2017","journal-title":"J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"11043","DOI":"10.1038\/s41598-018-29401-x","article-title":"A VSV-based Zika virus vaccine protects mice from lethal challenge","volume":"8","author":"Emanuel","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1080\/21645515.2018.1473698","article-title":"The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials","volume":"14","author":"Suder","year":"2018","journal-title":"Hum. Vaccines Immunother."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/11\/631\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:29:33Z","timestamp":1760196573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/10\/11\/631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":74,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"alternative-id":["v10110631"],"URL":"https:\/\/doi.org\/10.3390\/v10110631","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]}}}